Join our
Investor Newsletter

To receive Investor News as it is released please sign up

News Releases

Second Price Monitoring Extn

September 16, 2021
RNS Number : 0377M Renalytix PLC 16 September 2021   Second Price Monitoring Extension A second and final Price Monitoring Extension has been activated in this security. The auction call period is extended in this security for a further 5 minutes. Following the first price monitoring extension this

Second Price Monitoring Extn

September 15, 2021
RNS Number : 8680L Renalytix PLC 15 September 2021   Second Price Monitoring Extension A second and final Price Monitoring Extension has been activated in this security. The auction call period is extended in this security for a further 5 minutes. Following the first price monitoring extension this

Price Monitoring Extension

September 15, 2021
RNS Number : 8670L Renalytix PLC 15 September 2021   Price Monitoring Extension The auction call period has been extended in this security by 5 minutes. Auction call extensions give London Stock Exchange electronic order book users a further opportunity to review the prices and sizes of orders

Update on MCIT Rule

September 14, 2021
RNS Number : 7773L Renalytix PLC 14 September 2021   This announcement contains inside information   Renalytix plc (" Renalytix " or the " Company ")   Update on MCIT Rule to Provide National Medicare Coverage for FDA Breakthrough Devices and Diagnostics   NEW YORK , September 14, 2021 - Renalytix

Mount Sinai Initiates Scale-Up of KidneyIntelX

September 14, 2021
RNS Number : 6348L Renalytix PLC 14 September 2021   This announcement contains inside information   Renalytix plc (" Renalytix " or the " Company ")     Mount Sinai Initiates System-wide Scale-Up of Renalytix KidneyIntelX TM Enabled Health Care Model   Targeted testing run rate of 300 diabetic

Issue of shares and TVR

September 13, 2021
RNS Number : 6078L Renalytix PLC 13 September 2021       Renalytix plc (" Renalytix " or the " Company ")     Issue of shares under the 2020 employee share purchase plan and Total Voting Rights   NEW YORK and SALT LAKE CITY , September 13 2021 - Renalytix Plc   (NASDAQ: RNLX) (LSE: RENX)  

Director/PDMR Shareholding

September 6, 2021
RNS Number : 8886K Renalytix PLC 06 September 2021   Renalytix plc (" Renalytix " or the " Company ")     Director/PDMR Dealing   New York , 6 September 2021 - Renalytix (LSE: RENX) announces that it has been advised of the sale by O. James Sterling , the Company's Chief Financial Officer, of 3,000

Presentation at 2021 Wells Fargo Healthcare Conf.

September 3, 2021
RNS Number : 6161K Renalytix PLC 03 September 2021     Renalytix plc (" Renalytix " or the " Company ")     Renalytix to present at the 2021 Wells Fargo Virtual Healthcare Conference   NEW YORK and SALT LAKE CITY , September 3, 2021 -- Renalytix plc (LSE: RENX) (NASDAQ: RNLX) announces that the
Displaying 1 - 10 of 231